Novo Nordisk wins German approval to buy Akero Therapeutics
MLex Summary: Pharmaceuticals company Novo Nordisk has won approval from the German competition authority to acquire Akero Therapeutics. The Bundeskartellamt reviewed the deal based on the transaction-value threshold, and concluded that...To view the full article, register now.
Already a subscriber? Click here to view full article